Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Altered Expression of Neddylation Pathway Proteins in Myelodysplastic Syndromes

Fatemeh Majidi, MD, Judith Neukirchen, MD, Simon Brille, Iris Fey, BSc., Frank Neumann, MDPhD, Allison Berger, PhD, Ron-Patrick Cadeddu, PhD, Martina Rudelius, MD, Ulrich Germing, MD, Rainer Haas, MD, Norbert Gattermann, MD

Blood (2017) 130 (Supplement 1): 5298.

https://doi.org/10.1182/blood.V130.Suppl_1.5298.5298

Published: 2017

Journal Articles

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

Blood (2017) 130 (Supplement 1): 1562.

https://doi.org/10.1182/blood.V130.Suppl_1.1562.1562

Published: 2017

Journal Articles

JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma

Antonio Solimando, MD, Andreas Brandl, PhD, Mattenheimer Katharina, Carolin Graf, Miriram Ritz, Anna Ruckdeschel, Thorsten Stühmer, PhD, Martina Rudelius, MD, Maria Antonia Frassanito, PhD, Rosenwald Andreas, MD, Franz Jakob, MD, Angelo Vacca, MD, Hermann Einsele, MD, Andreas Beilhack, MD

Blood (2016) 128 (22): 307.

https://doi.org/10.1182/blood.V128.22.307.307

Published: 2016

Journal Articles

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Blood (2014) 124 (21): 2014.

https://doi.org/10.1182/blood.V124.21.2014.2014

Published: 2014

Journal Articles

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

Alexander Hoellein, MD, Stephanie Schoeffmann, Fallahi Mohammad, PhD, John L Cleveland, PhD, Johannes Gloeckner, PhD, Marius Ueffing, PhD, Martina Rudelius, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 3107.

https://doi.org/10.1182/blood.V124.21.3107.3107

Published: 2014

Journal Articles

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Sabine Steidle, MD, Tobias Dechow, MD, Katharina Götze, Martina Rudelius, MD, Konstanze Pechloff, PhD, Kerstin Behnke, Lars Bullinger, MD PhD, Falko Fend, MD, Soberon Valeria, PhDstudent, Marc Schmidt-Supprian, PhD, Florian Bassermann, MD, Jürgen Ruland, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 648.

https://doi.org/10.1182/blood.V124.21.648.648

Published: 2014

Journal Articles

Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Catharina Müller-Thomas, MD, Martina Rudelius, MD, Ina Rondak, PhD, Torsten Haferlach, MD, Julie Schanz, MD, Burkhard Schmidt, MD, Markus Kremer, MD, Ulrich Germing, MD, Uwe Platzbecker, MD, PhD, Christian Peschel, Katharina Götze, MD

Blood (2013) 122 (21): 2797.

https://doi.org/10.1182/blood.V122.21.2797.2797

Published: 2013

Journal Articles

Activated Sumoylation Is a Hallmark Of Burkitt's Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors

Alexander Hoellein, MD, Sabine Steidle, MD, Mohammad Fellahi, PhD, Stephanie Schoeffmann, Martina Rudelius, MD, Christian Peschel, John L Cleveland, Ulrich Keller

Blood (2013) 122 (21): 3783.

https://doi.org/10.1182/blood.V122.21.3783.3783

Published: 2013

Journal Articles

PTEN Regulates SYK-Directed AKT Activation in MCL.

Martina Rudelius, MD, Stefania Pittaluga, MD, PhD, Denise Sebasigari, Theresa Davies-Hill, Margit Klier, Leticia Quintanilla-Martinez, MD, Falko Fend, Prof, Yoko Tabe, Mark Raffeld, MD

Blood (2009) 114 (22): 2941.

https://doi.org/10.1182/blood.V114.22.2941.2941

Published: 2009

Journal Articles

The MDM2 Antagonist Nutlin-3 Is Lethal to Mantle Cell Lymphoma with Wild Type p53.

Yoko Tabe, MD, Denise Sebasigari, BA, Martina Rudelius, MD, Stefania Pittaluga, MD, PhD, Mark Raffel, MD

Blood (2007) 110 (11): 1382.

https://doi.org/10.1182/blood.V110.11.1382.1382

Published: 2007

Journal Articles

C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway.

Natasa Anastasov, PhD, Martina Rudelius, MD, Margit Klier, Therese Dau, Daniela Angermeier, Stefania Pittaluga, PhD, MD, Justus Duyster, MD, Falko Fend, MD, Mark Raffeld, MD, Leticia Quintanilla-Martinez, PD., MD

Blood (2007) 110 (11): 3570.

https://doi.org/10.1182/blood.V110.11.3570.3570

Published: 2007

Journal Articles

The BCR-Associated Tyrosine Kinase SYK Is Linked to the Activation of AKT in Mantle Cell Lymphoma.

Martina Rudelius, MD, Denise Sebasigari, BA, Yoko Tabe, MD, Theresa Davies-Hill, BA, Falko Fend, MD, Quintanilla-Martinez Leticia, MD, Jaffe S. Elaine, MD, Pittaluga Stefania, MD, PhD, Raffeld Mark, MD

Blood (2007) 110 (11): 1586.

https://doi.org/10.1182/blood.V110.11.1586.1586

Published: 2007

Journal Articles

Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma.

Martina Rudelius, MD, Stefania Pittaluga, MD, Trinh H.-T. Pham, Thomas Fountaine, III, Leticia Quintanilla-Martinez, MD, Falko Fend, MD, Elaine S. Jaffe, MD, Mark Raffeld, MD

Blood (2005) 106 (11): 1908.

https://doi.org/10.1182/blood.V106.11.1908.1908

Published: 2005

NARROW

Altered Expression of Neddylation Pathway Proteins in Myelodysplastic Syndromes

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Activated Sumoylation Is a Hallmark Of Burkitt's Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors

PTEN Regulates SYK-Directed AKT Activation in MCL.

The MDM2 Antagonist Nutlin-3 Is Lethal to Mantle Cell Lymphoma with Wild Type p53.

C/EBPβ Expression in ALK+ Anaplastic Large Cell Lymphomas (ALCL) Is Regulated by Stat3 Signaling Pathway.

The BCR-Associated Tyrosine Kinase SYK Is Linked to the Activation of AKT in Mantle Cell Lymphoma.

Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only